iifl-logo

Kopran Ltd Share Price

192.66
(2.86%)
Apr 2, 2025|12:14:51 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open187.5
  • Day's High195.25
  • 52 Wk High369.7
  • Prev. Close187.31
  • Day's Low183.4
  • 52 Wk Low 156.01
  • Turnover (lac)339.89
  • P/E26.9
  • Face Value10
  • Book Value90.13
  • EPS6.95
  • Mkt. Cap (Cr.)930.27
  • Div. Yield1.6
View All Historical Data
No Records Found

Kopran Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

187.5

Prev. Close

187.31

Turnover(Lac.)

339.89

Day's High

195.25

Day's Low

183.4

52 Week's High

369.7

52 Week's Low

156.01

Book Value

90.13

Face Value

10

Mkt Cap (₹ Cr.)

930.27

P/E

26.9

EPS

6.95

Divi. Yield

1.6

Kopran Ltd Corporate Action

16 May 2024

12:00 AM

Dividend

Dividend Amount: 3

arrow

19 Aug 2024

12:00 AM

BookCloser

arrow

19 Aug 2024

12:00 AM

AGM

Announcement Date: 19 Aug, 2024

arrow

20 Mar 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Kopran Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Kopran Ltd SHAREHOLDING SNAPSHOT

02 Apr, 2025|12:39 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 44.45%

Foreign: 0.00%

Indian: 44.45%

Non-Promoter- 0.87%

Institutions: 0.86%

Non-Institutions: 54.67%

Custodian: 0.00%

Share Price

Kopran Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

48.21

48.21

48.21

43.25

Preference Capital

0

0

0

0

Reserves

368.66

347.38

330.51

203.6

Net Worth

416.87

395.59

378.72

246.85

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

204.52

222.83

179.29

153.69

yoy growth (%)

-8.21

24.28

16.65

-15.33

Raw materials

-127.82

-137.74

-101.16

-91.24

As % of sales

62.5

61.81

56.42

59.36

Employee costs

-21.05

-18.33

-20.02

-18.33

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

16.16

32.7

15.73

6.96

Depreciation

-4.32

-4.1

-3.47

-3.22

Tax paid

-4.42

-9.23

-4.51

-2.25

Working capital

53.98

-10.52

14.2

-0.58

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-8.21

24.28

16.65

-15.33

Op profit growth

-48.96

30.3

158.76

-48.38

EBIT growth

-47.64

68.3

59.58

-41.25

Net profit growth

-49.96

109.2

138.37

-44.65

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

614.59

550.99

477.52

491.81

359.5

Excise Duty

0

0

0

0

0

Net Sales

614.59

550.99

477.52

491.81

359.5

Other Operating Income

0

0

0

0

0

Other Income

14.61

3.07

10.6

17.99

0.63

Kopran Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,698.35

129.244,07,155.151,181.050.85,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,549.7

71.051,47,295.245940.542,297513.62

Cipla Ltd

CIPLA

1,444.25

25.071,16,664.331,438.150.94,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,183.9

59.031,07,673.274850.882,330222.38

Mankind Pharma Ltd

MANKIND

2,458.1

52.421,01,358.17416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Kopran Ltd

Management

Register Office

Registrar Office

Executive Vice Chairman

Surendra Somani

Company Sec. & Compli. Officer

Sunil Sodhani

Independent Director

Siddhan Subramanian

Independent Director

Sunita Banerji

Independent Director

Mamta Biyani

Independent Director

Narayan Atal

Chairman (Non-Executive)

Susheel Somani

Non Executive Director

Adarsh Somani

Non Executive Director

Varun Somani

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Kopran Ltd., incorporated on April 26, 1958, was promoted by the Somani group and is controlled by Parijat Enterprises. The company came out with a public issue at a premium, in Nov.92, to finance its backward integration project to produce drug intermediates for semi-synthetic drugs, and also to expand its antibiotic facility.Kopran manufactures pharmaceutical finished dosage forms and bulk drugs and distributes electronic equipment. It manufactures semi-synthetic penicillin and is among the worlds highest producers in amoxycillin. Kopran also makes penicillin-G acylase, an enzyme made through fermentation. It has technical collaborations with Gesellschaft Fur Biotechnologische, Germany; Yuhan Corporation, South Korea; Ciba Corning Diagnostic, US; and Adac Laboratories, US.Koprans bulk drug plant has been approved by the US FDA and the UK regulatory authorities. In 1995, the company was awarded the Quality Excellence award by the Indian Drug Manufacturers Association. Koprans high growth rate in exports has been recognised by a number of awards from CHEMEXCIL and the Ministry of Commerce.The company launched new products like AZ-1 Caps, Klodip Tabs, Moclox Kid Tabs, Amyn Kid Tabs, Tini-NF, Amyn Caps and Amyn Dry Syrup. Kopran entered into a joint venture with M/s Industrial Promotion Services Ltd to take over a running unit viz Kampala Pharmaceuticals Industries Ltd in Uganda.The company has been ranked as amongst the top few fastest growing companies in India(ORG Marg-June
Read More

Company FAQs

What is the Kopran Ltd share price today?

The Kopran Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹192.66 today.

What is the Market Cap of Kopran Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Kopran Ltd is ₹930.27 Cr. as of 02 Apr ‘25

What is the PE and PB ratio of Kopran Ltd?

The PE and PB ratios of Kopran Ltd is 26.9 and 2.18 as of 02 Apr ‘25

What is the 52 Week High and Low of Kopran Ltd?

The 52-week high/low is the highest and lowest price at which a Kopran Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Kopran Ltd is ₹156.01 and ₹369.7 as of 02 Apr ‘25

What is the CAGR of Kopran Ltd?

Kopran Ltd's CAGR for 5 Years at 51.85%, 3 Years at -14.03%, 1 Year at -30.73%, 6 Month at -43.74%, 3 Month at -11.94% and 1 Month at 9.23%.

What is the shareholding pattern of Kopran Ltd?

The shareholding pattern of Kopran Ltd is as follows:
Promoters - 44.45 %
Institutions - 0.87 %
Public - 54.67 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.